Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2026-01-03 @ 9:15 PM
Study NCT ID:
NCT02830451
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-10
First Post:
2016-06-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metastatic Tumor Research and Outcomes Network
Sponsor:
AO Innovation Translation Center
Organization:
Study Overview
Official Title:
Metastatic Tumor Research and Outcome Network A Multicenter Prospective Registry for the Management and Outcome of Metastatic Spine Tumors
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2025-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MTRON
Brief Summary:
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Detailed Description:
To prospectively determine the prognostic variables (clinical, diagnostic, and therapeutic) within patients diagnosed with metastatic spine tumor(s) that are associated with:
* patient reported outcomes (HRQOL)
* morbidity data
* local tumor control
* survival
Outcome measures:
Variables which will be collected in the registry that are applicable to patients with metastatic spine tumor include:
* • Patient details
* Details of previous treatment
* Diagnosis
* Symptoms
* Treatment details for the index target
* Imaging information
The following outcome measures will be collected:
* Patient reported outcomes:
* Euroqol EQ-5D-3L
* Euroqol EQ-5D VAS - Quality of Life
* Neck Pain Numeric Rating Scale (NRS)
* Arm Pain NRS
* Back Pain NRS
* Leg Pain NRS
* SOSGOQ
* Patient assessment
* Ambulation
* Pain medication
* Nutritional Status Tool (PG-SGA©)
* Morbidity data
* Local disease recurrence data
* Overall survival data
* patient reported outcomes (HRQOL)
* morbidity data
* local tumor control
* survival
Outcome measures:
Variables which will be collected in the registry that are applicable to patients with metastatic spine tumor include:
* • Patient details
* Details of previous treatment
* Diagnosis
* Symptoms
* Treatment details for the index target
* Imaging information
The following outcome measures will be collected:
* Patient reported outcomes:
* Euroqol EQ-5D-3L
* Euroqol EQ-5D VAS - Quality of Life
* Neck Pain Numeric Rating Scale (NRS)
* Arm Pain NRS
* Back Pain NRS
* Leg Pain NRS
* SOSGOQ
* Patient assessment
* Ambulation
* Pain medication
* Nutritional Status Tool (PG-SGA©)
* Morbidity data
* Local disease recurrence data
* Overall survival data
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: